Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: AWD, TDS, FVT

Synthetic Biology Industry Gathers at SynBioBeta 2020 Global Summit to Grow the Bioeconomy, Fight the Pandemic, and Honor CRISPR Pioneer Jennifer Doudna

SAN FRANCISCO, Sept. 28, 2020 /PRNewswire/ -- SynBioBeta, the leading community of biological engineers, investors, innovators, and entrepreneurs to build a better world with biology, announced the schedule for its 2020 Global Synthetic Biology Summit.

The Summit will feature such luminaries as Tristan Harris (Center for Humane Technology), George Church (Harvard), Jennifer Holmgren (LanzaTech), Christina Smolke (Antheia), Sylvia Wolf (AquaBounty), Ed Boyden (MIT), and Timothy Lu (MIT).

Despite the economic slowdown of COVID, synthetic biology startups raised a record-setting $3.0 billion in the first half of 2020. While funding is strong for tools and technologies companies  -- the engine of the bioeconomy -- there is increasing investment in synthetic biology-enabled companies in consumer products, food, agriculture, medicine, chemicals, materials, and other manufacturing sectors, signaling the impact tech and biology is poised to have on every industry.

"This year, the pandemic has brought previously unimaginable challenges to our community, not just how we meet and work, but more importantly, how we respond to the society's urgent needs," said John Cumbers, founder and CEO of SynBioBeta, which earlier in the year hosted a series of events on synthetic biology and the pandemic. "Synthetic biology is ready to turn today's industry on its head and revolutionize the way we do business. In the same way that every company today is in some way an Internet company, every company will one day be a biology company. SynBioBeta 2020 is the place to get ahead of the curve."

This year's conference will explore how engineered biology will disrupt consumer products, food, agriculture, medicine, chemicals, materials, and more. Sessions include:

Each year, SynBioBeta is honored to recognize synthetic biology leaders who embody the best of this industry and the aims it seeks to achieve. This year's winners are an exceptional group of innovators who have helped the community grow while making profound contributions to society:

About SynBioBeta 2020
SynBioBeta 2020 is the Global Synthetic Biology Conference that unites leading biological engineers, investors, innovators, and entrepreneurs who are building the future with biology. This year's digital offering gives you even more ways to connect, including our annual conference, new events and grand challenges, access to online content and groups, and AI-powered networking. Learn the latest technologies, hear the big announcements in the field, make new partnerships, meet investors, and discover new companies. Learn more and register here.

About SynBioBeta
SynBioBeta is the leading community of innovators, investors, engineers, and thinkers who share a passion for using synthetic biology to build a better, more sustainable universe. We create and energize innovation communities to make the impossible possible via unparalleled opportunities for growth, networking, storytelling, and learning.

SynBioBeta offers a weekly industry digest, The Bioeconomy Hub membership program, the SynBioBeta Podcast, Good Genes magazine, and educational courses ? in addition to providing our world-class industry partners with opportunities for advertising, partnership, trade show exhibition, strategic consultation, and promotion.

For more information, visit www.synbiobeta.com.

Contact: Amanda Prieto, amanda.prieto@synbiobeta.com, (707) 344-8279

Related Images

Nobel Laureate Frances Arnold Receives 2019 SynBioBeta Award
Nobel Laureate Frances Arnold received 2019 SynBioBeta Award from SynBioBeta founder John Cumbers


These press releases may also interest you

at 07:05
Applova Inc., the Palo Alto order-ahead technology, announces the release of restaurant analytics for independent restaurants, food trucks, kiosks and small chains. Applova's restaurant analytics is a plug and play tool that collects every datapoint...

at 07:05
Ocular Therapeutixtm, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report third quarter financial...

at 07:05
ASICLine has quickly grabbed the attention of crypto investors around the world since the recent launch of its miners. The two 5nm ASIC miners https://asicline.com from the company website, FirstLine and PowerBox have been designed with the sole...

at 07:00
Milestone Pharmaceuticals Inc. , a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the pricing of its previously announced...

at 07:00
WiMi Hologram Cloud, Inc. ("WiMi" or the "Company") ,  a leading augmented reality service provider in China, today announced that that it has retained ICR, LLC, a leading strategic communications advisory firm, to manage its investor relations...

at 07:00
symplr, a leading global healthcare governance, risk management, and compliance ("GRC") software-as-a-service ("SaaS") platform, backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and SkyKnight Capital (together with...

News published on 28 september 2020 at 18:17 and distributed by: